Type 1 Diabetes

Latest News

Screening for T1D in Children May Help Reduce Morbidity

A public health screening for islet autoantibodies demonstrated prevalence of 0.31 percent among children aged 2 to 5 years.

Is Bariatric Surgery Still Effective 5 Years Later for Diabetes Remission?

By

Alyssa Capel

The aims of the study were to discover efficacy of bariatric surgery for remission of diseases related to obesity, estimate metabolic changes over 5 years, and compare the outcomes of restrictive and gastric bypass surgeries.

Medtronic Recalls Certain MiniMed Insulin Pumps After Injuries Reported

By

Brian Park, PharmD

Medtronic is recalling certain MiniMed 600 Series insulin pumps due to a missing or broken retainer ring that can potentially lead to the under or over delivery of insulin.

Defined Formulary, Negotiated Prices Could Save Medicare Billions on Insulin Prescriptions

Using negotiated prices and a defined formulary, similar to the Department of Veterans Affairs, Medicare could save billions of dollars on prescription insulin for patients with diabetes.

Glucagon Emergency Kit Now Available for Severe Hypoglycemia

By

Brian Park, PharmD

Fresenius Kabi announced the launch of Glucagon Emergency Kit for the treatment of severe hypoglycemic episodes in adult and pediatric patients with diabetes.

Benefits of Insulin Plus Pramlintide in Artificial Pancreas Systems

By

Amit Akirov, MD

A novel dual-hormone artificial pancreas system that delivers both rapid insulin and pramlintide was found to improve glucose control.

Patients With Chronic Pancreatitis at Increased Risk for Diabetes Emergencies

By

Amit Akirov, MD

Chronic pancreatitis is associated with increased risk for diabetes-associated emergencies, including diabetic ketoacidosis.

CGM Improves Metabolic Control, Reduces DKA and Severe Hypoglycemia in Pediatric T1D

By

Morgan E. Meissner

Real-world use of continuous glucose monitoring systems improves glycemic control and reduces the frequency of rare and dangerous events in pediatric type 1 diabetes.

Continuous Glucose Monitoring in Youth With Cystic Fibrosis May Detect Early Diabetes

By

Endocrinology Advisor Contributing Writer

Continuous glucose monitoring may provide a better understanding of the early stages of diabetes progression in youth with cystic fibrosis.

Mobile Closed-Loop Insulin System Lowers Hypoglycemia Risk in Type 1 Diabetes

By

Morgan E. Meissner

Automated insulin delivery by a mobile closed-loop control system represents a feasible option for glycemic control in type 1 diabetes, with some improvements still needed in device connectivity.

Study Compares Cesarean Delivery Rates After Induced Labor in Women With Diabetes

In women with prepregnancy type 1 and 2 diabetes, induction of labor is not associated with increased cesarean section rates compared with expectant management beyond 39 weeks, but it is associated with certain neonatal adverse outcomes.

Telemedicine Care May Improve Management of Patients With Type 1 Diabetes

By

Amit Akirov, MD

Researchers explored the effects of a telemedicine visit on care in patients with T1D.

Increased Risk for Psychiatric Disorders in Adolescents, Emerging Adults With Diabetes

By

Amit Akirov, MD

Adolescence and emerging adulthood represent a complicated stage for patients with T1D. Access to mental health services during this transition is critical.

Severe Hypoglycemia Linked to Worse Cognition in Older Patients With T1D

Both recent severe hypoglycemia (SH) and lifetime SH are associated with worse cognition among older adults with type 1 diabetes.

Study Explores Factors Affecting Glycemic Control in T1D

Patients with type 1 diabetes with optimal and suboptimal glycemic control differ with respect to clinical and health care utilization factors.

Intermittently Scanned CGM May Reduce Hypoglycemia in T1D

Intermittently scanned continuous glucose monitoring results in higher treatment satisfaction among adults with type 1 diabetes.

FDA Approves Mealtime Insulin Option for Pediatric Patients With Diabetes

By

Diana Ernst, RPh

The approval was based on data from an active-controlled, treat-to-target trial (Onset7) that included 777 pediatric patients (aged 2 to 17 years) with type 1 diabetes.

High Lipoprotein(a) Is a Risk Factor for CVD in Type 1 Diabetes

For patients with type 1 diabetes, lipoprotein(a) [Lp(a)] is a significant risk factor for macrovascular disease, albuminuria, and calcified aortic valve disease.

Suicide and Type 1 Diabetes: Importance of Risk Assessment in Young Patients

By

Amit Akirov, MD

Assessment of suicide risk as part of routine pediatric type 1 diabetes care is feasible and necessary.

ADA 2020 Standards of Care Incorporate CVD Risk Stratification, New Medications

By

Rachael Beairsto

The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.